Influence of Improved Formula on Fatty Acids and Mineral Metabolism in Infants
NCT ID: NCT02587702
Last Updated: 2015-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Feeding Infant Formula With Enriched Protein Fractions
NCT02274883
Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants
NCT00480948
The Effects of Dietary Palmitic Acid Triacylglyceride Position on Bone Strength Parameters in Infants
NCT00874068
Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China
NCT01373541
Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants
NCT02073071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Improved Infant Formula Group
Containing β-Palmitate Content
β-Palmitate Content
General Infant Formula Group
Excluding β-Palmitate Content
Placebo
Human Milk Group
Containing β-Palmitate Content Naturely in Human Milk
β-Palmitate Content Naturely in Human Milk
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
β-Palmitate Content
Placebo
β-Palmitate Content Naturely in Human Milk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* neonatal morbidities, or metabolic illness
7 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Jiao Tong University School of Medicine
OTHER
Beingmate Baby & Child Food Co Ltd .
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Children's Medical Center
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RDM2012002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.